Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on: May 21,2024

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on:May 21,2024

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

October 2023Katie RobinsonPatients undergoing a human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplantation (alloHCT) with reduced-intensity conditioning who received a prophyl

Updated on: February 18,2024

Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Bests Standard Regimen in Phase III Study

October 2023Katie RobinsonPatients undergoing a human leukocyte antigen (HLA)-matched allogeneic hematopoietic cell transplantation (alloHCT) with reduced-intensity conditioning who received a prophyl

Updated on:February 18,2024

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on: March 09,2024

Pancreatic tumors may require a one-two-three punch

by University of Rochester Medical CenterThe colors in this cell culture show action taken by pancreas cancer when it recruits harmful cells to the tumor that suppress the body’s natural immune s

Updated on:March 09,2024

Novel checklist for 'quality of life' to take cancer clinical trials to the next level

byEuropean Society for Medical OncologyCredit:Annals of Oncology(2022). DOI: 10.1016/j.annonc.2022.12.004The European Society for Medical Oncology (ESMO) has developed a quality of l

Updated on: January 11,2024

Novel checklist for 'quality of life' to take cancer clinical trials to the next level

byEuropean Society for Medical OncologyCredit:Annals of Oncology(2022). DOI: 10.1016/j.annonc.2022.12.004The European Society for Medical Oncology (ESMO) has developed a quality of l

Updated on:January 11,2024

Placebo pill eases cancer-related fatigue in study

by Alan MozesPatients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease.Now, a new investigation may have landed

Updated on: March 06,2024

Placebo pill eases cancer-related fatigue in study

by Alan MozesPatients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease.Now, a new investigation may have landed

Updated on:March 06,2024

On-the-move cancer cells prefer a 'comfort cruise,' follow predictable paths of least resistance

by Spencer Turney,Vanderbilt UniversityA cancer cell migrating through a collagen track with fluorescent biomarkers showing cellular energy levels assigned a hue on the color spectrum from purpl

Updated on: May 13,2024

On-the-move cancer cells prefer a 'comfort cruise,' follow predictable paths of least resistance

by Spencer Turney,Vanderbilt UniversityA cancer cell migrating through a collagen track with fluorescent biomarkers showing cellular energy levels assigned a hue on the color spectrum from purpl

Updated on:May 13,2024

HPV vaccine eliminates advanced skin cancer in 97-year-old

(HealthDay)—The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a

Updated on: March 12,2024

HPV vaccine eliminates advanced skin cancer in 97-year-old

(HealthDay)—The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a

Updated on:March 12,2024

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on: January 30,2024

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on:January 30,2024

Attacking metastatic breast cancer with sound

by Tohoku UniversityThe treatment is injected into one lymph node and travels via the lymphatic system to reach the cancerous one. Credit: Tohoku UniversityDrugs can be safely delivered to cancer

Updated on: May 11,2024

Attacking metastatic breast cancer with sound

by Tohoku UniversityThe treatment is injected into one lymph node and travels via the lymphatic system to reach the cancerous one. Credit: Tohoku UniversityDrugs can be safely delivered to cancer

Updated on:May 11,2024

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179

Updated on: January 30,2024

Researchers find superantigen mutant can trigger immune response in ovarian cancer cells

by Liu Jia,Chinese Academy of SciencesThe transwell co-culture models of transcriptome experiment. Credit:International Journal of Molecular Sciences(2023). DOI: 10.3390/ijms24141179

Updated on:January 30,2024

New multimodal signature could predict immunotherapy success

byUniversity of InnsbruckCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110529An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC)

Updated on: September 27,2024

New multimodal signature could predict immunotherapy success

byUniversity of InnsbruckCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110529An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC)

Updated on:September 27,2024

Reversing chemotherapy resistance in pancreatic cancer

byStanford UniversityCredit: CC0 Public DomainPancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy. Now, researcher

Updated on: July 05,2024

Reversing chemotherapy resistance in pancreatic cancer

byStanford UniversityCredit: CC0 Public DomainPancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy. Now, researcher

Updated on:July 05,2024